 |
Fatty Acid Red Cell Analysis
Overview:
A new frontier in
medicine has awakened the exploration of
three-dimensional metabolics through red cell
fatty acid analysis. Through revolutionary
finite lipid research and analysis, spearheaded
by Patricia Kane, Ph.D. at BodyBio Corporation,
utilizing the leading laboratory John Hopkins
Kennedy Krieger Institute, BodyBio has opened a
door that leads to clarity of cell membrane
dynamics.
The BodyBio Fatty Acid Analysis, conducted
through a standard blood draw, provides
practitioners with an incredible view into the
fatty acid metabolism of their patients. This
analysis can lead to more accurate diagnosis and
positive treatment outcomes for many health
conditions.
Disturbances in fatty acid metabolism are now
rapidly being linked to a myriad of physical and
mental disorders. The bilipid layer surrounding
every cell and organelle serves as more than
protection; it is the very essence of life with
vibrant electrical activity providing gates in
and out of each cell. Insight into this
marvelous "body ionic" membrane system is
possible through examination of red cell fatty
acid profiling. This analysis can be reflective
of long-term insufficiencies and imbalances in
fatty acid metabolism.
Plasma (the liquid portion of the blood) fatty
acids reflect recent dietary intake rather than
metabolic conversion (12-14 weeks) observed in
fatty acids incorporated into red cell
membranes. Exploration of fatty acid metabolism
leads the clinician to a wide realm of metabolic
strategies to influence the health of the
patient. Lipids evolve into hormones, the
bilipid layer of every cell in the body,
prostaglandins, immune components, and myelin.
There is virtually no system of the body that
does not require attention of specific fatty
acid substrates and coenzymes to maintain health
and repair of bodily tissues.
Examination of patients with conditions such as cardiovascular disease, endocrine imbalance, cognitive impairment, immune dysfunction, gastrointestinal difficulties, anxiety, chronic fatigue, MS, ALS. Alzheimers disease, Autism, Parkinsons disease, infertility, eating disorders, depression, epilepsy, PMS, skin disorders, neurological impairment, developmental delay and traumatic brain injury reveal characteristic patterns that may be addressed with targeted lipid manipulation and stabilization of the membrane traffic through electrolytes and metabolic nutritional therapy.
Ultimately, within the body of the BodyBio Fatty
Acid Report, the Patient Nutritional
Intervention section details the specific foods
the patient should incorporate or avoid in their
diet. A true breakthrough in medical
diagnostics.
|
 |
|
|
|
|
|
|
